Optiscan Imaging’s shares surge by up to 22.5% to A$0.120, marking their highest level since November 14, 2023.
The stock is poised for its most significant single-day gain since November 14, if the current uptrend continues.
The Australian medical imaging technology company announces a collaboration agreement with the Mayo Clinic, focusing on the development of a digital confocal laser endomicroscopic imaging system for application in robotic surgery.
Trading activity sees approximately 591,624 shares exchanged, surpassing the 30-day average volume of 304,140 shares.
Year-to-date, the stock has appreciated by 16.7% as of the previous close.
Source: tredingview.com
